Intas B2B is an active pharmaceutical licensor, proudly supplying 140+ different finished products to 90+ partners in 50+ countries. It has a strong presence in Europe and other regions, including Canada, Australia, LATAM, ASIA and the Middle East. It is composed of a full-fledged, global support team of 40 people (from offices in Barcelona and around the globe) to cater to the demand of its valued customers. The team is a young and passionate one that combines creative, technical, and strategic talents with teamwork, trust, respect, and innovation.
Intas B2B portfolio is constantly growing across multiple therapeutic areas, specialised in CNS and Cardiovascular. Intas Intellectual Property department is one of Intas B2B’s important pillars, helping achieve ‘day one launches’ which will help ensure better accessibility of high-quality medicines across the globe.
Comments
Post a Comment